Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Mulder H, Eland D, Hackeng WH, Schopman W. Decrease of serum testosterone by cyproterone acetate accompanied by an unexpected increase of calcitonin secretion capacity. J Urol 1987;138:324-5. [PMID: 2955132 DOI: 10.1016/s0022-5347(17)43135-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]

For:	Mulder H, Eland D, Hackeng WH, Schopman W. Decrease of serum testosterone by cyproterone acetate accompanied by an unexpected increase of calcitonin secretion capacity. J Urol 1987;138:324-5. [PMID: 2955132 DOI: 10.1016/s0022-5347(17)43135-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]

Number

Cited by Other Article(s)

Kayigil O, Atahan O, Metin A. Cyproterone acetate monotherapy in advanced prostatic carcinoma. Int Urol Nephrol 1997;29:213-20. [PMID: 9241550 DOI: 10.1007/bf02551344] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]

Goldenberg SL, Bruchovsky N. Use of Cyproterone Acetate in Prostate Cancer. Urol Clin North Am 1991. [DOI: 10.1016/s0094-0143(21)01398-7] [Citation(s) in RCA: 24] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]